SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001387131-22-000611
Filing Date
2022-01-21
Accepted
2022-01-21 18:29:14
Documents
1
Period of Report
2022-01-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 - ALLOGENE THERAPEUTICS, INC. allo-form3_011222.html 3  
1 FORM 3 - ALLOGENE THERAPEUTICS, INC. allo-form3_011222.xml 3 7401
  Complete submission text file 0001387131-22-000611.txt   9435
Mailing Address C/O GOLDMAN, SACHS & CO. 85 BROAD STREET NEW YORK NY 10004
Business Address
WINKELRIED JON (Reporting) CIK: 0001366946 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 22547027

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Reporting) CIK: 0001903793 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 22547028